Ian A Rowe1, David J Mutimer. Show Affiliations » 1. Liver and Hepatobiliary Unit, Queen Elizabeth Hospital Birmingham, Birmingham B15 2TH, UK.
Abstract
Entities: Chemical
Mesh： See more » Cost-Benefit AnalysisDrug InteractionsDrug MonitoringGenotypeHepacivirus/drug effectsHepacivirus/geneticsHepatitis C/drug therapyHepatitis C/geneticsHumansOligopeptides/adverse effectsOligopeptides/therapeutic useProline/adverse effectsProline/analogs & derivativesProline/therapeutic useProtease Inhibitors/adverse effectsProtease Inhibitors/therapeutic useRandomized Controlled Trials as Topic
Substances： See more » OligopeptidesProtease InhibitorstelaprevirN-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamideProline
Year: 2011 PMID： 22074942 DOI： 10.1136/bmj.d6972
Source DB: PubMed Journal: BMJ ISSN： 0959-8138